Zomedica Corp.
ZOMDF
$0.10
$0.00-0.29%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 8.80M | 10.47M | 8.10M | 6.96M | 6.50M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 8.80M | 10.47M | 8.10M | 6.96M | 6.50M |
| Cost of Revenue | 3.32M | 3.30M | 2.66M | 2.30M | 2.09M |
| Gross Profit | 5.48M | 7.17M | 5.44M | 4.67M | 4.41M |
| SG&A Expenses | 9.23M | 10.69M | 10.26M | 10.82M | 11.27M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 13.70M | 15.64M | 14.70M | 15.00M | 15.22M |
| Operating Income | -4.90M | -5.16M | -6.61M | -8.04M | -8.72M |
| Income Before Tax | -4.50M | -4.74M | -6.14M | -7.39M | -63.87M |
| Income Tax Expenses | 39.00K | -214.00K | -19.00K | 12.00K | -57.00K |
| Earnings from Continuing Operations | -4.53M | -4.53M | -6.12M | -7.40M | -63.81M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -4.53M | -4.53M | -6.12M | -7.40M | -63.81M |
| EBIT | -4.90M | -5.16M | -6.61M | -8.04M | -8.72M |
| EBITDA | -3.01M | -3.25M | -4.71M | -6.11M | -6.50M |
| EPS Basic | 0.00 | 0.00 | -0.01 | -0.01 | -0.07 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 |
| EPS Diluted | 0.00 | 0.00 | -0.01 | -0.01 | -0.07 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 |
| Average Basic Shares Outstanding | 979.95M | 979.95M | 979.95M | 979.95M | 979.95M |
| Average Diluted Shares Outstanding | 979.95M | 979.95M | 979.95M | 979.95M | 979.95M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |